In vitro and in vivo assays demonstrated that downregulation of EIF4G2 could inhibit HCC cell growth, metastasis and tumorigenesis through suppression of the ERK signaling pathway. The gene discussed is EIF4G2; the disease is hepatocellular carcinoma.